AGN-231868

· AbbVie

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGN-231868, covering 2025-05-20 to 2025-05-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease [Phase 1, Phase 2]